STOCK TITAN

Vivakor Financials

VIVK
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Vivakor (VIVK) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VIVK FY2025

Vivakor’s gross-margin improvement is being overwhelmed by a heavier overhead base and a chronically tight short-term funding posture.

Between FY2024 and FY2025, gross margin jumped from 11.4% to 36.2%. But operating cash flow swung from $1.8M to -$15.8M, showing that better spread at the gross line was not enough to offset a much larger corporate cost burden and cash tied up elsewhere in the operating cycle.

FY2025’s gross profit of $37.7M still failed to cover selling and administrative expense of $43.0M, so improved unit economics never reached operating income. The overhead step-up was sharp, rising from $12.2M in FY2024, which makes the latest loss profile look more like a cost-structure problem than a purely low-margin one.

The balance sheet is defined more by near-term liquidity pressure than by simple leverage labels: FY2025 debt-to-equity was 1.8x, while the current ratio was only 0.1x. With just $265K of cash against $61.5M of current liabilities, routine operations appear dependent on creditor patience or external funding rather than internally generated cash.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&D Intensity Revenue Progress Burn Trend Balance Sheet 16 / 100
Financial Health Score 16/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Vivakor's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
1
Dilution
13
Revenue Progress
80
Burn Trend
1
Balance Sheet
2
Altman Z-Score Distress
-3.99

Vivakor scores -3.99, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($3.3M) relative to total liabilities ($76.3M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
4/8

Vivakor passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.14x

For every $1 of reported earnings, Vivakor generates $0.14 in operating cash flow (-$15.8M OCF vs -$110.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$104.4M
YoY+76.0%

Vivakor generated $104.4M in revenue in fiscal year 2026. This represents an increase of 76.0% from the prior year.

EBITDA
-$45.8M
YoY-1811.1%

Vivakor's EBITDA was -$45.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1811.1% from the prior year.

Net Income
-$110.2M
YoY-917.4%

Vivakor reported -$110.2M in net income in fiscal year 2026. This represents a decrease of 917.4% from the prior year.

EPS (Diluted)
$-318.01

Vivakor earned $-318.01 per diluted share (EPS) in fiscal year 2026.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$265K
YoY-64.4%

Vivakor held $265K in cash against $0 in long-term debt as of fiscal year 2026.

Dividends Per Share
N/A
Shares Outstanding
154M

Vivakor had 154M shares outstanding in fiscal year 2026.

Margins & Returns

Gross Margin
36.1%
YoY+27.7pp

Vivakor's gross margin was 36.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 27.7 percentage points from the prior year.

Operating Margin
-61.1%
YoY-50.5pp

Vivakor's operating margin was -61.1% in fiscal year 2026, reflecting core business profitability. This is down 50.5 percentage points from the prior year.

Net Margin
-105.6%
YoY-87.3pp

Vivakor's net profit margin was -105.6% in fiscal year 2026, showing the share of revenue converted to profit. This is down 87.3 percentage points from the prior year.

Return on Equity
-296.4%
YoY-233.4pp

Vivakor's ROE was -296.4% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 233.4 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

VIVK Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $19.5M-7.3% $21.0M+23.7% $17.0M-41.6% $29.1M-22.1% $37.3M-10.4% $41.7M+161.9% $15.9M-1.6% $16.2M
Cost of Revenue $13.7M+610.4% -$2.7M-121.9% $12.3M-50.0% $24.5M-24.7% $32.6M-7.9% $35.4M+149.3% $14.2M-5.8% $15.1M
Gross Profit $5.7M-75.8% $23.7M+401.9% $4.7M+3.1% $4.6M-3.8% $4.8M-24.6% $6.3M+265.7% $1.7M+55.4% $1.1M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $5.6M-75.1% $22.4M+109.6% $10.7M+138.8% $4.5M-16.5% $5.4M+8.4% $5.0M+89.5% $2.6M-12.1% $3.0M
Operating Income -$2.4M+94.2% -$41.6M-360.4% -$9.0M-33.3% -$6.8M-5.2% -$6.4M+58.6% -$15.6M-694.8% -$2.0M+31.3% -$2.9M
Interest Expense N/A N/A $14.4M+229.4% $4.4M+287.6% $1.1M N/A $641K+33.6% $480K
Income Tax $0-100.0% $117K $0 $0 $0-100.0% $93K $0-100.0% $33K
Net Income -$4.6M+91.8% -$55.9M-63.0% -$34.3M-173.5% -$12.5M-66.4% -$7.5M+61.3% -$19.5M-1053.2% -$1.7M+49.0% -$3.3M
EPS (Diluted) $-2.32 N/A $-2.09-596.7% $-0.30+99.3% $-42.32 N/A $-0.06+50.0% $-0.12

VIVK Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $111.8M-1.5% $113.5M-29.1% $160.1M-34.5% $244.5M-1.5% $248.2M+3.0% $241.0M+232.3% $72.5M-1.5% $73.7M
Current Assets $9.2M+12.0% $8.2M-10.9% $9.2M-69.9% $30.6M+7.4% $28.5M+138.3% $12.0M+156.9% $4.7M-19.0% $5.8M
Cash & Equivalents $4K-98.3% $265K-11.6% $300K-27.6% $414K-45.9% $765K+17.6% $651K-5.3% $687K+623.6% $95K
Inventory $82K0.0% $82K-25.6% $111K-16.3% $132K0.0% $132K-35.6% $206K+11.2% $185K+146.0% $75K
Accounts Receivable $2.2M-37.5% $3.5M-39.5% $5.8M-68.2% $18.3M+41.6% $12.9M+694.9% $1.6M+135.2% $692K-79.5% $3.4M
Goodwill $0 $0-100.0% $40.6M-41.1% $68.9M0.0% $68.9M0.0% $68.9M+359.7% $15.0M0.0% $15.0M
Total Liabilities $78.1M+2.4% $76.3M-20.6% $96.1M-34.4% $146.5M+5.1% $139.4M+10.7% $125.9M+125.7% $55.8M-4.8% $58.6M
Current Liabilities $63.0M+2.3% $61.5M-19.6% $76.5M-43.9% $136.4M+7.0% $127.6M+12.4% $113.5M+140.8% $47.1M+7.8% $43.7M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $33.6M-9.5% $37.2M-45.4% $68.2M-33.3% $102.2M-9.5% $112.9M-1.9% $115.1M+585.3% $16.8M+11.7% $15.0M
Retained Earnings -$211.0M-3.3% -$204.3M-38.0% -$148.1M-32.1% -$112.1M-14.3% -$98.1M-10.2% -$89.0M-22.2% -$72.8M-2.4% -$71.1M

VIVK Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$3.3M+83.5% -$20.1M-277.9% $11.3M+261.8% -$7.0M-19943617.1% -$35-100.0% $1.6M+66.1% $991K-1.4% $1.0M
Capital Expenditures N/A N/A N/A N/A N/A N/A $186K-83.8% $1.1M
Free Cash Flow N/A N/A N/A N/A N/A N/A $805K+660.5% -$144K
Investing Cash Flow N/A -$26K+84.3% -$163K-143.0% $378K-74.5% $1.5M-44.4% $2.7M+1532.1% -$186K+83.8% -$1.1M
Financing Cash Flow $1.3M-93.8% $21.0M+254.5% -$13.6M-348.3% $5.5M+1580.0% -$370K+72.0% -$1.3M-521.9% -$212K+59.8% -$529K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

VIVK Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 29.4%-83.4pp 112.8%+85.0pp 27.8%+12.0pp 15.7%+3.0pp 12.7%-2.4pp 15.1%+4.3pp 10.8%+4.0pp 6.9%
Operating Margin -12.5%+185.5pp -198.0%-144.8pp -53.2%-29.9pp -23.3%-6.0pp -17.3%+20.1pp -37.3%-25.0pp -12.3%+5.3pp -17.6%
Net Margin -23.5%+242.6pp -266.1%-64.2pp -201.9%-158.8pp -43.1%-22.9pp -20.2%+26.5pp -46.7%-36.1pp -10.6%+9.9pp -20.5%
Return on Equity -13.6%+136.6pp -150.3%-100.0pp -50.3%-38.0pp -12.3%-5.6pp -6.7%+10.2pp -16.9%-6.9pp -10.1%+12.0pp -22.0%
Return on Assets -4.1%+45.1pp -49.2%-27.8pp -21.4%-16.3pp -5.1%-2.1pp -3.0%+5.0pp -8.1%-5.8pp -2.3%+2.2pp -4.5%
Current Ratio 0.15+0.0 0.13+0.0 0.12-0.1 0.220.0 0.22+0.1 0.110.0 0.10-0.0 0.13
Debt-to-Equity 2.32+0.3 2.05+0.6 1.41-0.0 1.43+0.2 1.24+0.1 1.09-2.2 3.32-0.6 3.90
FCF Margin N/A N/A N/A N/A N/A N/A 5.1%+5.9pp -0.9%

Note: The current ratio is below 1.0 (0.13), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Vivakor (VIVK) reported $104.4M in total revenue for fiscal year 2026. This represents a 76.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Vivakor (VIVK) revenue grew by 76% year-over-year, from $59.3M to $104.4M in fiscal year 2026.

No, Vivakor (VIVK) reported a net income of -$110.2M in fiscal year 2026, with a net profit margin of -105.6%.

Vivakor (VIVK) reported diluted earnings per share of $-318.01 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Vivakor (VIVK) had EBITDA of -$45.8M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Vivakor (VIVK) had a gross margin of 36.1% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Vivakor (VIVK) had an operating margin of -61.1% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Vivakor (VIVK) had a net profit margin of -105.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Vivakor (VIVK) has a return on equity of -296.4% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Vivakor (VIVK) generated -$15.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Vivakor (VIVK) had $113.5M in total assets as of fiscal year 2026, including both current and long-term assets.

Vivakor (VIVK) had 154M shares outstanding as of fiscal year 2026.

Vivakor (VIVK) had a current ratio of 0.13 as of fiscal year 2026, which is below 1.0, which may suggest potential liquidity concerns.

Vivakor (VIVK) had a debt-to-equity ratio of 2.05 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Vivakor (VIVK) had a return on assets of -97.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2026 data, Vivakor (VIVK) had $265K in cash against an annual operating cash burn of $15.8M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Vivakor (VIVK) has an Altman Z-Score of -3.99, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Vivakor (VIVK) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Vivakor (VIVK) has an earnings quality ratio of 0.14x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Vivakor (VIVK) scores 16 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top